Intervention
lisinopril
ClinicalTrials.gov intervention label
Clinical trials
19 shownA Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Lisinopril and Warfarin in Healthy SubjectsNCT02070510 · 2014-02-27
COMPLETEDLisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung CancerNCT01880528 · 2013-05-31
COMPLETEDNon-invasive Haemodynamic Assessment in HypertensionNCT01996085 · 2013-01-01
COMPLETEDA Pharmacodynamic/Pharmacokinetic Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus on Treatment With LisinoprilNCT01398267 · 2011-08-01
COMPLETEDBenazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid TumorsNCT01234922 · 2011-02-01
TERMINATEDLisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving TrastuzumabNCT01009918 · 2010-03-01
COMPLETEDVA NEPHRON-D: Diabetes iN Nephropathy StudyNCT00555217 · 2008-07-01
TERMINATEDThe Antihypertensives and Vascular, Endothelial and Cognitive Function TrialNCT00605072 · 2008-01-01
COMPLETEDEfficacy of Coreg CR and Lisinopril on Markers for Cardiovascular Functional and Structural DiseaseNCT00553969 · 2007-11-01
COMPLETEDVascular Benefits of Adding CarvedilolCR to Type2 Diabetic Patients on ACEI.NCT00430040 · 2007-02-01
TERMINATEDThe COREG And Lisinopril Combination Therapy In Hypertensive Subjects (COSMOS) TrialNCT00347360 · 2006-07-01
COMPLETEDEffect of Liraglutide on Gastrointestinal Absorption of Several Drugs and Potential Influence of Liraglutide on Intragastric pHNCT01518166 · 2006-05-01
COMPLETEDEvaluation of Periop Biochemical Stress Factors in Craniotomy Neurosurgical Procedure With Respect to Preop HypertensionNCT02441842 · 2006-03-01
COMPLETEDCOREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And MicroalbuminuriaNCT00123903 · 2005-07-01
TERMINATEDThe CLEVER Study - Coreg And Left Ventricular Mass RegressionNCT00108082 · 2005-01-01
COMPLETEDVALERIA: Valsartan in Combination With Lisinopril in Hypertensive Patients With MicroalbuminuriaNCT00171067 · 2004-07-01
COMPLETEDComparison Of Morning And Evening Dosing Of Valsartan And Lisinopril In Patients With DiabetesNCT00241124 · 2004-04-01
COMPLETEDAntihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)NCT00000542 · 1993-08-01
COMPLETEDRenoprotective Effect of Nisoldipine and Lisinopril in Type 1 Diabetic NephropathyNCT00311870 · 1993-03-01
COMPLETEDCommon conditions
Hypertension7Diabetes2Healthy2Aging1Arterial Hypertension1Breast Cancer1Cardiac Toxicity1Cardiovascular Diseases1Cognitive Impairment1Coronary Disease1Diabetes Mellitus1Diabetes Mellitus Type 21Diabetes Mellitus, Type 21Diabetic Nephropathy1Dyspnea1Heart Diseases1Heart Failure1Heart Failure, Congestive and Microalbuminuria1Hypercholesterolemia1Hypertrophy, Left Ventricular1Kidney Disease1Myocardial Infarction1Myocardial Ischemia1Nephropathy1Non-small Cell Lung Cancer1
Leading sponsors
GlaxoSmithKline3Novartis2Novo Nordisk A/S2Hoffmann-La Roche1Mayo Clinic1Military Institute od Medicine National Research Institute1Milton S. Hershey Medical Center1National Heart, Lung, and Blood Institute (NHLBI)1Steno Diabetes Center Copenhagen1University at Buffalo1University of Minnesota1University of South Florida1University of Southern California1US Department of Veterans Affairs1Wake Forest University Health Sciences1
Trial status mix
COMPLETED15
TERMINATED4
Phase mix
PHASE36
PHASE25
PHASE14
PHASE44
NA1
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.